Jiang et al. introduced LGALS2 and EGR1 as potential new targets for risk prediction and non-invasive diagnosis of endometriosis, providing the potential for personalized medical treatment of EM patients (Jiang et al., 2023). The gene discussed is LGALS2; the disease is erythema multiforme.